Supreme Cannabis Enters into Supply Agreements with Medical Cannabis by Shoppers

TORONTO, Nov. 12, 2020 /CNW/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that the Company has entered into a supply agreement with Medical Cannabis by Shoppers Inc., a subsidiary of Shoppers Drug Mart Inc. Under the terms of the supply agreement with Medical Cannabis by Shoppers Inc., theContinue reading “Supreme Cannabis Enters into Supply Agreements with Medical Cannabis by Shoppers”

Shoppers Drug Mart to expand Canadians’ access to virtual care through $75 million investment in Maple

– (TSX: L): Loblaw Companies Ltd (“Loblaw” or the “Company”) has taken a significant step forward on its journey to provide Canadians with the convenience and security of a digitally connected healthcare network. Today, the Company announced that its wholly owned subsidiary Shoppers Drug Mart Inc. (“Shoppers Drug Mart”) will invest $75 million in Maple Corporation (“Maple”), the leading virtualContinue reading “Shoppers Drug Mart to expand Canadians’ access to virtual care through $75 million investment in Maple”

Organigram Joins Medical Cannabis by Shoppers Inc. and TruTrace in Effort to Track Source and Genetics of Cannabis Used by Medical Patients

Project aims to match therapeutic outcomes to specific cannabis profiles and ensure consistent product for patients and healthcare practitioners –Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has partnered with Medical Cannabis by Shoppers™ (“Shoppers”) onContinue reading “Organigram Joins Medical Cannabis by Shoppers Inc. and TruTrace in Effort to Track Source and Genetics of Cannabis Used by Medical Patients”

Pat McCutcheon, CEO of MediPharm Labs to Present at the Avicanna Hosted Virtual Symposium Titled “Medical Cannabis 2.0” in Partnership with Medical Cannabis by Shoppers™

This year’s annual symposium coincides with the expected launch of Avicanna Inc’s (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) RHO Phyto™ advanced medical cannabis products, manufactured by MediPharm Labs. In the wake of COVID-19, a virtual format will be used that allows for a broader reach to global patients and the medical community. The symposium will present theContinue reading “Pat McCutcheon, CEO of MediPharm Labs to Present at the Avicanna Hosted Virtual Symposium Titled “Medical Cannabis 2.0” in Partnership with Medical Cannabis by Shoppers™”

Radient Technologies Inc. Announces Participation in a Medical Cannabis Study Led by the University Health Network in Partnership with Shoppers Drug Mart

— Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, is pleased to announce that bioU products by Radient will be available to patients in the recently announced University Health Networks’ (“UHN”)  Medical Cannabis Real-World Evidence Study (“MC-RWE Study”) in partnership with Medical Cannabis byContinue reading “Radient Technologies Inc. Announces Participation in a Medical Cannabis Study Led by the University Health Network in Partnership with Shoppers Drug Mart”

MediPharm Labs Selected by University Health Network and Medical Cannabis by Shoppers Inc. for First Real-World Evidence, Patient-Centred Clinical Trial Using Blockchain Technology

~20% of UHN products in study formulary, including 7 unique medical cannabis products, to be manufactured by MediPharm Labs  — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its participation in a ground-breaking collaboration between University Health Network (“UHN”) and MedicalContinue reading “MediPharm Labs Selected by University Health Network and Medical Cannabis by Shoppers Inc. for First Real-World Evidence, Patient-Centred Clinical Trial Using Blockchain Technology”

WeedMD Cultivars Included in UHN-led Chronic Pain Study

Company’s products on ‘Medical Cannabis by Shoppers’ platform, registered under blockchain-enabled program added to University Health Network’s research trials — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it is one of the first licensed producers (LP) to have its products and strains included in theContinue reading “WeedMD Cultivars Included in UHN-led Chronic Pain Study”

MPX International’s Subsidiary, Spartan Wellness, Enters Into a Services Agreement With Medical Cannabis by Shoppers Drug Mart Inc.

MPX International Corporation (the “Corporation” or “MPX”) (CSE: MPXI) is pleased to announce that its wholly-owned subsidiary, Spartan Wellness Corporation (“Spartan”), has entered into a services agreement, dated July 1, 2020 (the “Services Agreement”) with Medical Cannabis by Shoppers Drug Mart Inc., a subsidiary of Shoppers Drug Mart. Spartan was initially established by a group of concernedContinue reading “MPX International’s Subsidiary, Spartan Wellness, Enters Into a Services Agreement With Medical Cannabis by Shoppers Drug Mart Inc.”

MediPharm Labs Expands Innovative CBD Product Portfolio By Introducing CBD25:5 Release Formula

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced a further expansion of its innovative, pharma-quality family of branded products with the retail introduction of CBD25:5 Release Formula(“CBD25:5”). This latest brand – the third launched from MediPharm Labs’ GMP-certifiedContinue reading “MediPharm Labs Expands Innovative CBD Product Portfolio By Introducing CBD25:5 Release Formula”